Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S. FDA clearance of multiFiltratePRO ...
HHS kidney plan takes aim at dialysis market concentration, targeting DaVita and Fresenius' 74% market share to improve care and competition.
Fresenius Medical Care Presents New Research And Evidence-Driven Innovations Aimed At Improving Patient Outcomes During ASN Kidney Week 2026 CI Oct. 19 Fresenius Medical Care AG : Deutsche Bank ...
DaVita (DVA) stock sank 6% on Trump’s Kidney Care National Plan news—see market impact, key metrics, and what to watch ahead ...
Fresenius Medical Care Presents New Research And Evidence-Driven Innovations Aimed At Improving Patient Outcomes During ASN Kidney Week 2026 CI Oct. 19 Fresenius Medical Care AG : Deutsche Bank ...
DaVita (DVA) stock and Fresenius Medical Care (FMS) stock drops as Trump administration plans dialysis market reforms to boost competition. Read more here.
Fresenius Medical Care a présenté de nouvelles recherches et des innovations fondées sur les données probantes visant à améliorer les résultats pour les patients lors de la Semaine du ...
Fresenius Medical Care is presenting U.S. clinical research and technology-focused studies at ASN Kidney Week 2026 in Denver, October 21–25. Findings include real-world delivery ...
Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, presents new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results